Journal of Clinical Medicine (Oct 2022)

Imaging of GBM in the Age of Molecular Markers and MRI Guided Adaptive Radiation Therapy

  • Salah Dajani,
  • Virginia B. Hill,
  • John A. Kalapurakal,
  • Craig M. Horbinski,
  • Eric G. Nesbit,
  • Sean Sachdev,
  • Amulya Yalamanchili,
  • Tarita O. Thomas

DOI
https://doi.org/10.3390/jcm11195961
Journal volume & issue
Vol. 11, no. 19
p. 5961

Abstract

Read online

Glioblastoma (GBM) continues to be one of the most lethal malignancies and is almost always fatal. In this review article, the role of radiation therapy, systemic therapy, as well as the molecular basis of classifying GBM is described. Technological advances in the treatment of GBM are outlined as well as the diagnostic imaging characteristics of this tumor. In addition, factors that affect prognosis such as differentiating progression from treatment effect is discussed. The role of MRI guided radiation therapy and how this technology may provide a mechanism to improve the care of patients with this disease are described.

Keywords